Disease or not, aging is easily treatable

被引：38
作者：
Blagosklonny, Mikhail V. [1 ]
机构：
[1] Roswell Pk Canc Inst, Cell Stress Biol, Buffalo, NY 14263 USA
来源：
AGING-US | 2018年 / 10卷 / 11期
关键词：
gerossuppresants; senolytics; longevity; lifespan; EXTENDS LIFE-SPAN; DIABETES PREVENTION PROGRAM; BASAL-STATE HYPERINSULINEMIA; HEALTHY NORMOGLYCEMIC ADULTS; ALL-CAUSE MORTALITY; CALORIE RESTRICTION; CARDIOVASCULAR-DISEASE; GLUCOSE-TOLERANCE; CANCER PREVENTION; BREAST-CANCER;
D O I：
10.18632/aging.101647
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
Is aging a disease? It does not matter because aging is already treated using a combination of several clinicallyavailable drugs, including rapamycin. Whether aging is a disease depends on arbitrary definitions of both disease and aging. For treatment purposes, aging is a deadly disease (or more generally, pre-disease), despite being a normal continuation of normal organismal growth. It must and, importantly, can be successfully treated, thereby delaying classic age-related diseases such as cancer, cardiovascular and metabolic diseases, and neurodegeneration.
引用
收藏
页码：3067 / 3078
页数：12
相关论文
共 147 条
  • [61] Effect of Long-Term Metformin and Lifestyle in the Diabetes Prevention Program and Its Outcome Study on Coronary Artery Calcium
    Goldberg, Ronald B.
    Aroda, Vanita R.
    Bluemke, David A.
    Barrett-Connor, Elizabeth
    Budoff, Matthew
    Crandall, Jill P.
    Dabelea, Dana
    Horton, Edward S.
    Mather, Kieren J.
    Orchard, Trevor J.
    Schade, David
    Watson, Karol
    Temprosa, Marinella
    [J]. CIRCULATION, 2017, 136 (01) : 52 - +
  • [62] Effect of Metformin-Containing Antidiabetic Regimens on All-cause Mortality in Veterans With Type 2 Diabetes Mellitus
    Gosmanova, Elvira O.
    Canada, Robert B.
    Mangold, Therese A.
    Rawls, William N.
    Wall, Barry M.
    [J]. AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2008, 336 (03) : 241 - 247
  • [63] Beyond aspirin-cancer prevention with statins, metformin and bisphosphonates
    Gronich, Naomi
    Rennert, Gad
    [J]. NATURE REVIEWS CLINICAL ONCOLOGY, 2013, 10 (11) : 625 - 642
  • [64] Rapamycin fed late in life extends lifespan in genetically heterogeneous mice
    Harrison, David E.
    Strong, Randy
    Sharp, Zelton Dave
    Nelson, James F.
    Astle, Clinton M.
    Flurkey, Kevin
    Nadon, Nancy L.
    Wilkinson, J. Erby
    Frenkel, Krystyna
    Carter, Christy S.
    Pahor, Marco
    Javors, Martin A.
    Fernandez, Elizabeth
    Miller, Richard A.
    [J]. NATURE, 2009, 460 (7253) : 392 - U108
  • [65] Risk of Cause-Specific Death in Individuals with CancerModifying Role Diabetes, Statins and Metformin
    Haukka, Jari
    Niskanen, Leo
    Auvinen, Anssi
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2017, 141 (12) : 2437 - 2449
  • [66] Single Rapamycin Administration Induces Prolonged Downward Shift in Defended Body Weight in Rats
    Hebert, Mark
    Licursi, Maria
    Jensen, Brittany
    Baker, Ashley
    Milway, Steve
    Malsbury, Charles
    Grant, Virginia L.
    Adamec, Robert
    Hirasawa, Michiru
    Blundell, Jacqueline
    [J]. PLOS ONE, 2014, 9 (05):
  • [67] Repurposing metformin for the prevention of cancer and cancer recurrence
    Heckman-Stoddard, Brandy M.
    DeCensi, Andrea
    Sahasrabuddhe, Vikrant V.
    Ford, Leslie G.
    [J]. DIABETOLOGIA, 2017, 60 (09) : 1639 - 1647
  • [68] Hiding in plain view: the potential for commonly used drugs to reduce breast cancer mortality
    Holmes, Michelle D.
    Chen, Wendy Y.
    [J]. BREAST CANCER RESEARCH, 2012, 14 (06):
  • [69] Therapeutic Use of Metformin in Prediabetes and Diabetes Prevention
    Hostalek, Ulrike
    Gwilt, Mike
    Hildemann, Steven
    [J]. DRUGS, 2015, 75 (10) : 1071 - 1094
  • [70] Association of all-cause and cardiovascular mortality with prehypertension: A meta-analysis
    Huang, Yuli
    Su, Liang
    Cai, Xiaoyan
    Mai, Weiyi
    Wang, Sheng
    Hu, Yunzhao
    Wu, Yanxian
    Tang, Hongfeng
    Xu, Dingli
    [J]. AMERICAN HEART JOURNAL, 2014, 167 (02) : 160 - +
234567891011